StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) income statement

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$400.84−33.09 (-7.63%)

Close on Nov 18, 2026Market cap $86.60BP/E 17.1Yield –

Elevance Health, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
89.0%
Operating margin
2.7%
Net margin
2.5%
Return on equity, FY2025
13.3%

Financial strength

Current ratio
1.47
Debt to equity
0.69
Debt to assets
24.1%
Cash to current liabilities
22.2%

Valuation

P/E ratio
17.1
Price to sales
0.43
Price to book
1.94
Dividend yield
–

See a number that looks wrong?